Business Segments Cogstate Limited

Stocks

Market Closed - Australian S.E. 02:10:27 2026-09-04 EDT			5-day change	1st Jan Change
3.090 ^AUD	+0.65%		-0.96%	+36.73%

08-18	Cogstate Limited, 2026 Earnings Call, Aug 18, 2026
08-17	Cogstate Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI

Breakdown by Business Segment (AUD)

Fiscal Period: June	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Life Sciences Tools and Services
Clinical Trials (incl. Precision Recruitment Tool & Research)	-	-	39.44M	50.58M	58.37M
Gross Profit	-	-	21.43M	30.27M	33M
D&A	-	-	304K	312K	336K
	-	-	-	-	58.37M
Healthcare Industry Software
Healthcare (Incl. Sport)	4.46M	4.4M	3.99M	2.51M	2.5M
Gross Profit	3.24M	3.12M	2.87M	1.86M	2.02M
EBITDA	-	-	-	-	-
Operating Income	-	-	-	-	-
Clinical Trials (Incl. Precision Recruitment Tool)	40.33M	35.73M	-	-	-
Gross Profit	23.73M	18.03M	-	-	-
EBITDA	-	-	-	-	-
D&A	397K	200K	-	-	-
Operating Income	-	-	-	-	-
Research Solutions	196K	320K	-	-	-
Gross Profit	-688K	-499K	-	-	-
EBITDA	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	2.5M
Unallocated Administration	53.09K	703K	-	-	-
Gross Profit	53.09K	703K	-	-	-
D&A	1.93M	2.39M	-	-	-
Operating Income	-	-	-	-	-
Gross Profit	-	-	-	-	-

Geographical breakdown of sales (AUD)

Fiscal Period: June	2017	2018 (USD)	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)